By focusing on the MDM2–p53 axis dysfunction in the transformation of normal hepatocytes into hepatoma cells, we hoped to provide some clues for the liver cancer prevention and pre-HCC treatment strategies. The gene discussed is MDM2; the disease is hepatocellular carcinoma.